Opitz G/BBB syndrome (OS) is a congenital defect characterized by hypertelorism and hypospadias, but additional midline malformations are also common in OS patients. X-linked OS is caused by mutations in the ubiquitin ligase MID1. In chick, MID1 is involved in left-right determination: a mutually repressive relationship between Shh and cMid1 in Hensen's node plays a key role in establishing the avian left-right axis. We have utilized our existing knowledge of the molecular basis of avian L/R determination to investigate the possible existence of functional redundancy between MID1 and its close homologue MID2. The expression of cMid2 overlaps with that of cMid1 in the node, and we demonstrate that MID2 can both mimic MID1 function as a right side determinant and rescue the laterality defects caused by knocking down endogenous MID proteins in the node. Our results show that MID2 is able to compensate for an absence in MID1 during chick left-right determination and may explain why OS patients do not suffer laterality defects despite the association between midline and L/R development. The demonstration of functional redundancy between MID1 and MID2 in the node provides supports for the hypothesis that partial functional redundancy between MID proteins in other developing structures contributes to the wide variability of OS phenotype. D 2004 Elsevier Inc. All rights reserved.
Introduction
X-linked Opitz G/BBB syndrome (OS; OMIM 300000 and 145410), characterized by defective midline development, is associated with mutations in MID1 (Quaderi et al., 1997) . The principal features of OS are hypertelorism (abnormally wide distance between the eyes) and hypospadias (abnormal positioning of the opening of the urethra), but other midline defects, such as tracheoesophageal fistulas, cardiac malformations, and CNS defects, are also common in OS patients (De Falco et al., 2003) . There is considerable clinical variability in the presentation of OS, even among male patients from the same family sharing identical MID1 mutations (Cox et al., 2000) , suggesting that other factors are modifying the OS phenotype. Although OS is a rare disease, research into MID1 function is of significant clinical interest as MID1 represents one of the few genes associated with either Mendelian inherited mental retardation or cleft lip and/or palate. MID1 is a microtubule-associated member of the RBCC family of proteins (also known as the TRIM family) characterized by an N-terminal tripartite motif consisting of a RING finger, one or two B-boxes, and a coiled-coil domain (Reymond et al., 2001 ). In common with other RING finger proteins (Joazeiro and Weissman, 2000) , MID1 is a ubiquitin ligase: it specifically targets the microtubule-associated pool of the catalytic subunit of phosphatase 2A (PP2Ac) for degradation by binding to its alpha 4 (a4) regulatory subunit (Trockenbacher et al., 2001 ). MID2, closely related to MID1, is also microtubule-associated (Buchner et al., 1999; Perry et al., 1999) and able to bind a4 (Short et al., 2002;  Trockenbacher et al., 2001) . It has therefore been proposed that the variability of the OS phenotype can be attributed to partial functional redundancy between MID proteins in tissues where their expression domains overlap (Short et al., 2002) .
Improper development of the axial midline in vertebrates can cause both midline and laterality defects, and the involvement of the Sonic Hedgehog (SHH) and Nodal pathways in both midline and left-right (L/R) development provides a molecular basis for this association (Roessler and Muenke, 2001 ). The hypertelorism characteristic of OS is reminiscent of the hypertelorism displayed by patients with mutations in PTCH and GLI3, two known antagonists of the SHH pathway (Hahn et al., 1996; Johnson et al., 1996; Vortkamp et al., 1991) . This observation suggests that MID1 may act as an intracellular antagonist of the SHH pathway, prompting us to investigate whether MID1 plays a role in L/ R determination. We have previously shown that the chick MID1 orthologue, cMid1, is involved in establishing the avian left-right (L/R) axis (Granata and Quaderi, 2003) . L/R determination in chick involves the establishment of asymmetric gene expression in Hensen's node (Capdevila et al., 2000; Mercola and Levin, 2001 ): a mutually repressive interaction between Shh and cMid1 maintains asymmetric gene expression in the node by restricting Shh to the left, and cMid1 to the right, of Hensen's node (Granata and Quaderi, 2003) . The distinct signaling pathways on the left and right sides of the node transmit L/R information to the lateral plate mesoderm (LPM) and then on to the organ primordia, resulting in asymmetric morphogenesis (Capdevila et al., 2000; Mercola and Levin, 2001) . Incorrect patterning of the L/R axis is potentially life-threatening as it results in the abnormal positioning and patterning of the visceral organs (Capdevila et al., 2000; Mercola and Levin, 2001) .
Here, we have used the well-characterized molecular cascades involved in avian L/R determination to address the issue of functional redundancy between MID1 proteins. We show that cMid2 expression overlaps with that of cMid1 in Hensen's node and that MID2 can mimic MID1 as a right side determinant. Furthermore, we find that MID2 is able to rescue the L/R patterning defects caused by knocking down endogenous MID proteins expressed in Hensen's node. The demonstration of functional redundancy between MID proteins during avian L/R determination supports the hypothesis that the variability of the OS phenotype can be attributed to partial functional redundancy between MID proteins. Our results also suggest a possible explanation for the absence of laterality defects associated with OS.
Materials and methods
Cloning of 5V cMid2 cDNA 5V Mid2 cDNA sequences were cloned from poly(A)+ RNA derived from stage 13-15 chick embryos by 5V RACE-PCR using the SMARTTM RACE cDNA amplification kit (Invitrogen) and following manufacturer's instructions. The cMid2-specific primer used (cMid2.race3) has the following sequence: 5V-TCG CTG AGC GAC GCC ACT TGG TGA TCC-3V. RACE amplification products were cloned with the TOPO-TA cloning kit for sequencing (Invitrogen) following supplier's recommendations.
Expression constructs and antisense morpholinos
The mouse Mid2 coding region was PCR-amplified using BamHI and ClaI tailed primers and cloned into the BamHI/ClaI sites of the pCAB expression vector to generate pCAB.mMid2. The DR expression construct contains the portion of the cMid1 cDNA coding for residues 73-667 cloned into the BamHI/ClaI sites of the pCAB expression vector. The B-box expression construct contains the portion of the cMid1 cDNA coding for residues 111-165 cloned into the BamHI/ClaI sites of the pCAB expression vector. The DC expression construct contains the portion of the cMid1 cDNA coding for residues 1-307 cloned into the BamHI/ClaI sites of the pCAB expression vector. All the pCAB expression constructs detailed above contain an IRES-GFP cassette. pCAB.cMid1 and the morpholinos cMid1.mo (renamed cMid.MO) and control.mo have been previously described (Granata and Quaderi, 2003) .
Embryo culture and electroporations
Chick embryos were staged in accordance with Hambuger and Hamilton (1951) . A modified EC culture technique was used to transfer stage 4 embryos, dorsal side up with the vitelline membrane removed, into a small electroporation chamber containing a positive platinum electrode in its base. Embryos were positioned such that this electrode was on the left or on the right of Hensens node, as appropriate. pCAB.mMid2, pCAB.cMid1, pCAB.DR, pCAB.B-box, pCAB.DC, and pCAB.GFP were applied using a glass micropipette at 2 Ag/Al in 0.1% fast green for visualization. cMid.MO and control.MO were applied at 1 mM in 0.1% fast green for visualization. Electroporations were performed by placing a negative tungsten electrode over the DNA (or morpholino) solution and applying four square pulses (5 V, 50 ms) using an Intracept TSS10 dual-pulse isolated stimulator (Intracel, UK). Embryos were then grown ventral side up as EC cultures (Chapman et al., 2001) until the appropriate stage. GFP/fluorescein fluorescence was used to monitor the position and efficiency of electroporation.
Whole-mount in situ hybridization and immunostaining
A 758-bp cMid2 5V RACE clone was used as a template for riboprobe generation. Whole-mount in situ hybrid-ization and immunostaining were performed using standard techniques.
Results
A single EST representing the chick MID2 orthologue, cMid2, was identified in the BBSRC ChickEST Database (www.chick.umist.ac.uk; clone ID ChEST660F7); however, this clone covers only part of the Mid2 coding region and lacks both the 5V and 3V ends. Screening of a stage 12-14 chick embryo cDNA library using the cMid2 EST clone only identified clones representing cMid1. 5V RACE PCR was performed on cDNA derived from stage 13-15 chick embryos, and clones covering the cMid2 5V coding region and UTR were recovered. This 5V cMid2 cDNA sequence has been deposited in GenBank (accession number AY546077). We were unable to clone the 3V cMid2 coding region. Whole-mount in situ RNA hybridization was used to determine the cMid2 expression pattern during early development ( Fig. 1) . Comparison of the cMid1 and cMid2 expression patterns shows that they are both expressed symmetrically in Hensen's node at stage 4 (Figs. 1B, C). cMid2 expression is not detected before this stage. cMid1 is first detected at stage 2 in a small, symmetrical anterior domain (Fig. 1A) . By stage 3, cMid1 expression is more intense and has expanded to form a crescent-shaped domain (Fig. 1E ). cMid1/2 expression is down-regulated on the left side of the node by stage 5 ( Fig.  1D ; Granata and Quaderi, 2003) , and this asymmetric expression is evident until stage 7 ( Fig. 1F ; Granata and Quaderi, 2003) . The anterior crescent-shaped cMid1 expression domain ( Fig. 1C ; Granata and Quaderi, 2003) is not shared by cMid2 (Figs. 1B, D) , and only cMid2 is expressed in the anterior primitive streak and extraembryonic tissue (Figs. 1B, G). At stage 8, both cMid1 and cMid2 are expressed in the neural plate, but cMid1 has a more posterior limit of expression (Figs. 1G and H) . cMid1 expression is excluded from the most medial (ventral) region of the neural plate (Fig. 1H ), but cMid2 expression is at a uniform level throughout the width of the neural plate (Fig. 1G ). cMid1 expression in the somites and lateral plate mesoderm ( Fig. 1H) is not shared by cMid2 (Fig. 1G) .
We have previously shown that misexpressing MID1 on the left side of Hensen's node results in ectopic expression of right pathway markers (e.g., Fgf8; Boettger et al., 1999) and repression of left pathway markers (e.g., Shh; Levin et al., 1995) (Granata and Quaderi, 2003) . To investigate whether misexpression of MID2 could also disrupt normal L/R molecular asymmetries in an analogous manner, we focally electroporated an expression vector carrying a mouse Mid2-IRES-GFP insert (pCAB.mMid2) into the left side of Hensen's node in stage 4 embryos ( Fig. 2A) . Mouse Mid2 was used as we were unable to clone the entire cMid2 coding region. Embryos were cultured to stage 6 and then assayed for either Shh or Fgf8 expression. Embryos electroporated with pCAB.mMid2 showed an absence of Shh expression in the node (n = 5/5; 100%; expressing only GFP (pCAB.GFP) showed no change in Shh (n = 4/4; Fig. 2B ; also Granata and Quaderi, 2003) or Fgf8 (n = 4/4; Fig. 2D ; also Granata and Quaderi, 2003) expression. These results indicate that MID2 is able to mimic MID1 function as a right side determinant, with respect to Shh and Fgf8 expression, when misexpressed on the left side of Hensen's node.
Knocking down right-sided MID1 expression in the node using an antisense morpholino, cMid1.mo, inhibits the expression of right pathway markers and induces the ectopic expression of the left pathway on the right side of the embryo (Granata and Quaderi, 2003) . cMid1.mo was designed to target the first 25 coding nucleotides of the cMid1 cDNA sequence. Comparison of 5V cMid1 and cMid2 sequences shows that there are only 2/25 mismatches in this region between cMid2 and cMid1.mo (Fig. 3) . At least 4/25 mismatches are required to prevent efficient binding of a morpholino to a target sequence (www.genetools.com). Therefore, it is probable that cMid1.mo (from now on referred to as cMid.MO) binds to both cMid1 and cMid2, thereby blocking the translation of both MID proteins. Consequently, the laterality defects caused by focally electroporating cMid.MO into the node could be the result of knocking down both MID1 and MID2 in the node, rather than MID1 alone. If this is the case, and if MID1 and MID2 are functionally redundant with respect to L/R determination, overexpression of MID2 on the right side of the node should be able to rescue the L/R defects caused by cMid.MO treatment. If, however, there is no functional redundancy between MID1 and MID2, overexpression of MID2 should have no effect on the L/R defects caused by cMid.MO treatment. In order to investigate whether MID2, in the absence of MID1, is sufficient for correct establishment of the L/R axis, we have used the expression vector pCAB.mMid2 to try and rescue the laterality defects caused by treatment with cMid.MO. cMid.MO was focally electroporated into the right side of Hensen's node at stage 4 (Fig.  4A ). Embryos were cultured to stage 6, fixed, and assayed for either Fgf8 or Shh expression. Fgf8 expression was absent from the node (n = 5/5; 100%; Fig. 4B ; also Granata and Quaderi, 2003) , and Shh was expressed bilaterally in the node (n = 5/5; 100%; Fig. 4H ; also Granata and Quaderi, 2003) in these embryos. No change in normal Fgf8 (n = 6/6; 100%; Fig. 4C ; also Granata and Quaderi, 2003) or Shh (n = 5/5; 100%; Fig. 4I ; also Granata and Quaderi, 2003) expression was seen in embryos electroporated with a control morpholino (control.MO). Co-electroporation of pCAB.GFP and cMid.MO has the same effect as electroporations with cMid.MO alone. Co-electroporated embryos show an absence of Fgf8 expression in the node (n = 4/5; 80%; Fig. 4D ) and bilateral Shh expression in the node (n = 5/5;100%; Fig. 4J ). However, co-electroporation of pCAB. mMid2 with cMid.MO results in the rescue of the molecular laterality defects seen with electroporation of cMid.MO alone: Fgf8 expression is restricted to the right side of the node (n = 8/10;80%; Fig. 4E ), while Shh expression is restricted to the left side (n = 8/9;89%; Fig. 4K ). Coelectroporation of pCAB.mMid2 and control.MO on the right side of the node in stage 4 embryos results in rightsided Fgf8 expression (n = 4/4; 100%; Fig. 4F ) and leftsided Shh expression (n = 4/4; 100%; Fig. 4L ) in the node at stage 6, indicating that overexpression of MID2 on the right side of the node in the presence of normal background levels of MID1/2 does not disrupt correct L/R determination. The typical extent of overlap between pCAB.cMid2 (or pCAB.GFP) expression and cMid.MO (or control.MO) transfection at stage 6 in co-electroporated embryos is shown (Fig. 4G ). Co-electroporations using pCAB.cMid1, rather than pCAB.cMid2, with cMid.MO also showed normal Fgf8 and Shh expression, indicating that the presence of either MID protein in the node is sufficient for the correct establishment of the L/R axis (data not shown).
MID1 and MID2 are members of the RBCC family of proteins. In addition to the RING finger, B-boxes, and coiled-coil domain that characterize this family, the MID Fig. 3 . 5V cMid1 and cMid2 sequences are highly conserved. There are only 2/25 mismatches in the first 25 coding nucleotides between cMid1 and cMid2. The amino acid sequence is perfectly conserved in this region. proteins also contain a conserved C terminal domain of unknown function (B30.2 domain) shared by a subset of RBCC proteins (Reymond et al., 2001) . Human MID1 and MID2 show an overall level of 84% similarity and 77% identity at the amino acid level (Buchner et al., 1999) . Experiments performed in vitro have provided insight into the roles of the various domains of the MID proteins. Most OS-causing MID1 mutations lie within the C-terminal and are associated with a loss of MID1 microtubule localization, indicating that microtubule association is mediated through the C-terminal and is essential for correct MID1 function Cox et al., 2000; De Falco et al., 2003; Gaudenz et al., 1998; Quaderi et al., 1997; Schweiger et al., 1999) . The coiled-coil domain has been shown to mediate MID protein dimerization: both MID1 and MID2 are able to homodimerize, but there is conflicting evidence regarding the ability of MID proteins to heterodimerize Short et al., 2002) . The a4 regulatory subunit of PP2A selectively binds to the B-box 1 sequence of both MID1 and MID2 and does not bind to B-box sequences derived from any other RBCC proteins (Liu et al., 2001; Short et al., 2002; Trockenbacher et al., 2001) . A variety of RING finger containing proteins has been shown to act as E3 ubiquitin ligases by binding to both E2 ubiquitin-conjugating enzymes, via the RING finger domain, and the target protein destined for degradation (Joazeiro and Weissman, 2000) . Although an E2 enzyme has yet to be identified that binds to MID proteins, the ubiquitination and subsequent degradation of PP2Ac are seen to be MID1-dependent (Trockenbacher et al., 2001) .
The vast majority of OS-associated mutations disrupt the MID1 C-terminus, leaving the N-terminal tripartite motif intact. Conflicting theories exist as to whether OS is caused by gain-of-function mutations in MID1, through deregulated activity of the intact tripartite motif (Schweiger et al., 1999) or by loss-of-function mutations in MID1 (Cox et al., 2000) . We have generated a MID1 expression construct lacking the C-terminus (pCAB.DC; Fig. 5 ) in order to test in vivo whether the isolated MID1 tripartite motif behaves as a gain-of-function isoform. We have also generated two further MID1 deletion constructs (pCAB.DR and pCAB.B-box; Fig. 5 ) to test whether the in vivo function of MID protein domains is consistent with the observed in vitro biochemical function. If the in vitro model for MID function is correct, we can predict that both these constructs will behave as dominant negatives when electroporated into MID-expressing cells as they should both block the targeting of PP2Ac for ubiquitin-mediated degradation: the DR construct blocks recruitment of an E2 enzyme, and the B-box construct blocks binding to a4. The DR construct lacks the RING finger domain (Fig. 5 ). This construct should be able to bind a4 (through B-box 1) and localize to microtubules (through the C terminal domain). However, as this construct lacks a RING finger, it is unable to bind to an E2 enzyme. In vitro binding studies have shown that the dnakedT B-box 1 sequence has a much greater affinity for a4 than the B-box 1 sequence in the context of a MID protein (Trockenbacher et al., 2001) . Overexpression of the B-box construct into MID-expressing cells is predicted to outcompete both MID1 and MID2 in binding a4 and, in common with the DR construct, prevent the ubiquitination and subsequent degradation of PP2Ac.
The cMid1 expression vector, pCAB.cMID1, was focally electroporated into the right side of Hensen's node in stage 4 embryos (Fig. 6A ). Embryos were cultured to stage 6 and then assayed for either Fgf8 or Shh expression. Fgf8 expression was confined to the right side of the node (n = 4/4; 100%; Fig. 6B ), while Shh expression was confined to the left side of the node (n = 4/4; 100%; Fig.  6H ). These results show that overexpressing MID1 within the endogenous MID1/2 expression domain on the right side of the node has no effect on normal L/R determination. Electroporation of DC into the right side of the node in stage 4 embryos has no effect on normal L/R patterning at stage 6, suggesting that DC is a loss-offunction construct: Fgf8 expression is restricted to the right (n = 12/12; 100%; Fig. 6E ), and Shh expression is restricted to the left (n = 9/9; 100%; Fig. 6K ). Embryos co-electroporated with DC and cMid.MO also show normal Shh and Fgf8 expression (data not shown). These results do not support a dominant negative role for the MID1 tripartite motif and instead are consistent with OS being a manifestation of loss-of-function mutations in MID1.
Electroporation of the DR construct into the right side of the node in stage 4 embryos results in defective L/R patterning by stage 6: electroporated embryos lack Fgf8 expression in the node (n = 12/14; 86%; Fig. 6C ) or have bilateral Shh expression in the node (n = 14/16; 88%; Fig. 6I ). Similarly, embryos electroporated with the B-box construct also lack Fgf8 expression in the node (n = 13/16; 81%; Fig. 6D ) or have bilateral Shh expression (n = 16/18; 89%; Fig. 6J ). These results are consistent with our A. Granata et al. / Developmental Biology 277 (2005) [417] [418] [419] [420] [421] [422] [423] [424] prediction that the DR and B-box constructs act to block endogenous MID function in a dominant negative manner and support the in vitro model for MID1 domain functions. These two constructs will provide a valuable alternative to cMid.MO for investigating the consequences of blocking MID function in other developing organ systems.
Given that correct MID function in vitro appears dependent on association with a4, we have investigated whether a4 is expressed in Hensens node. Several EST clones representing the chick a4 orthologue were identified in the BBSRC ChickEST Database (www.chick.umist.ac.uk; template sequence 339799.6). EST clone ChEST463i11 was used as a template to generate an antisense RNA probe for use in whole-mount in situ hybridization. Weak a4 expression is first seen on both sides of Hensens node at stage 4 (data not shown). At stage 5, when cMid1 and cMid2 are already confined to the right, a4 expression is still symmetric in the node (Fig. 6F ), but its expression is restricted to the right side by stage 6 (Fig. 6G) . Expression remains asymmetric at stage 7 and is down-regulated by stage 8 (data not shown).
Discussion
The chick homologue of the Opitz syndrome gene, cMid1, is involved in the establishment of asymmetric gene expression in Hensen's node: a key step in patterning the avian L/R axis (Granata and Quaderi, 2003) . We have utilized our existing knowledge of the molecular pathways involved in avian L/R determination to investigate whether functional redundancy exists between MID proteins. We have also used the L/R system to determine whether OS is associated with loss-of-function or gain-of-function MID1 mutations and whether MID1 function in vivo is consistent with in vitro biochemical data.
cMid1 and cMid2 are co-expressed on the right side of Hensen's node between stages 5 and 7. We have shown that when misexpressed on the left side of the node, MID2 can mimic MID1 in repressing endogenous Shh expression and inducing ectopic Fgf8 expression. Furthermore, we show that overexpression of MID2 on the right side of the node can rescue the laterality defects caused by treatment with cMid.MO. The antisense morpholino cMid.MO was originally designed to target the first 25 coding nucleotides of the cMid1 sequence, and it was assumed that the L/R patterning defects caused by cMid.MO were a result of knocking down MID1 alone (Granata and Quaderi, 2003) . We now show that the expression of cMid1 in the node is shared by cMid2 and that there are only two mismatches between cMid1 and cMid2 in the 5V region targeted by cMid.MO. As at least 4/25 mismatches are recommended to prevent binding of antisense morpholinos to their target sequences and up to 11/25 mismatches are used in practice (Sheng et al., 2003) , it is likely that cMid.MO binds to both cMid1 and cMid2. We have been unable to raise antibodies that reliably detect chick MID proteins and so are unable to test directly whether cMid.MO blocks the translation of either endogenous MID1 or MID2. However, the set of control electroporations performed strongly indicates that the laterality defects caused by cMid.MO are the specific result of knocking down endogenous MID1/2 expression in the node and that the rescue of these defects is through the specific action of exogenous MID2.
The DC MID1 deletion construct, containing the Nterminal tripartite domain but lacking the C-terminus, is representative of the vast majority of MID1 mutations associated with OS. DC acts as a nonfunctional MID1 construct, indicating that OS is likely to be a manifestation of loss-of-function, rather than gain-of-function, mutations in MID1. The observation that the DR and B box constructs both block endogenous MID activity in a dominant negative manner indicates that the in vivo function of the MID1 protein domains is consistent with their biochemical activity observed in vitro. Furthermore, the results of blocking MID function using the dominant negative DR and B box constructs are consistent with the results obtained from blocking MID function using antisense morpholinos.
The demonstration of functional redundancy between MID proteins during avian L/R determination suggests that functional redundancy between MID proteins could exist in other systems where they are co-expressed. It is notable that we have used mouse MID2 to compensate for an absence of chick MID1, as this indicates that MID function is well conserved both between species (mouse and chick) and homologues (MID1 and MID2). Our results support the hypothesis that the phenotypic variability in OS can be attributed to functional redundancy between MID1 and MID2, although further studies are required to prove this hypothesis. In addition to the node, we have seen partial overlap between cMid1 and cMid2 expressions in the anterior neural plate. However, we have also identified regions, such as the primitive streak and the developing somites, where only a single cMid gene is expressed, indicating that there are structures in the developing embryo where MID1 and MID2 have a nonredundant function. Further studies will focus on examining whether functional redundancy between MID proteins exists in developing midline structures affected in OS.
Although there is an association between midline and laterality defects Yost, 1995, 1996; Lohr et al., 1997; Roessler and Muenke, 2001; Yost, 1998) , L/R defects are not a typical feature of OS. This may reflect the fact that the mechanisms of early L/R determination are poorly conserved between species, and MID1 is not required for patterning the human L/R axis (Capdevila et al., 2000; Levin, 2003) . However, our results indicate that the absence of laterality defects in OS patients does not necessarily preclude the involvement of MID1 in human L/R determination: it is possible that MID2 might compensate for an absence of MID1 during the establishment of the L/R axis in individuals with OS. A recent study suggests that similarities in the anatomy of early embryos, rather than taxonomic similarities, may be a key factor in shared mechanisms of early L/R patterning among species (Fischer et al., 2002) : Fgf8 is a right determinant in chicks and rabbits, both of which develop as a flat blastodisc, but is a left determinant in mouse, although both mice and rabbits are mammals (Boettger et al., 1999; Fischer et al., 2002; Meyers and Martin, 1999) . As human embryos also develop as a flat blastodisc, factors found to play an early role in L/R determination in chick or rabbit, such as the MID1 proteins, may have a conserved function in establishing the human L/R axis.
